Immix Biopharma, Inc. IMMX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s software and technology licenses, net?
- Immix Biopharma, Inc. (IMMX) reported software and technology licenses, net of $20.42K in Q1 2026.
- How has Immix Biopharma, Inc.'s software and technology licenses, net changed year-over-year?
- Immix Biopharma, Inc.'s software and technology licenses, net decreased by 0.0% year-over-year, from $20.42K to $20.42K.
- What is the long-term trend for Immix Biopharma, Inc.'s software and technology licenses, net?
- Over 2 years (2022 to 2025), Immix Biopharma, Inc.'s software and technology licenses, net has grown at a 74.3% compound annual growth rate (CAGR), from $6.72K to $20.42K.